Analyzing Nitrosamines with Hydrogen Carrier Gas: GC/MS/MS Analysis of Nitrosamines in Sartan Drugs

Application Note Pharma & Biopharma Quantification of Nitrosamine Impurities in Sartan Drugs Using an Agilent GC/TQ with Hydrogen Carrier Gas Authors Abstract Soma Dasgupta, Vivek Dhyani, Anastasia Andrianova, and Joel Ferrer Agilent Technologies, Inc. In response to helium scarcity, labs…

Application Note Pharma & Biopharma Quantification of Nine Nitrosamine Impurities in Sartan Drugs Using an Agilent GC-TQ Authors Soma Dasgupta, Vivek Dhyani, and Melissa Churley Agilent Technologies, Inc. Abstract In this application note, a method for the analysis of nine…

Nitrosamines Analysis in Pharmaceuticals Using Single Quadrupole GC/MS or Triple Quadrupole GC/MS Consumables workflow ordering guide R1 N N R2 R O 2 R 1 R N N 2 R 1 R O R 2 1 N N N N…

Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…